Cellectar biosciences announces shane lea as chief commercial officer

Florham park, n.j., nov. 30, 2022 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the appointment of shane lea as its chief commercial officer, effective november 21, 2022.
CLRB Ratings Summary
CLRB Quant Ranking